The table below details the consideration transferred to acquire Novellus:
| Conversion | Estimated | |||||||
|
(in thousands, except per share amounts) |
Calculation | Fair Value | ||||||
|
Lam common stock issued at merger |
82,689 | |||||||
|
Per share price of Lam common stock as of June 4, 2012 |
$ | 35.99 | $ | 2,975,977 | ||||
|
|
|
|||||||
|
Estimated fair value of vested Lam equivalent restricted stock (1) |
$ | 9,599 | ||||||
|
Estimated fair value of vested Lam equivalent stock options (2) |
41,412 | |||||||
|
|
|
|||||||
|
Estimated purchase price consideration |
$ | 3,026,988 | ||||||
|
|
|
|||||||
| (1) | The fair value of Lam Research equivalent restricted stock as of the acquisition date was estimated based upon the per share price of Lam Research common stock as of June 4, 2012, and giving effect to the exchange ratio of 1.125. |
| (2) | The fair value of the Lam Research equivalent stock options as of the acquisition date was estimated using the Black-Scholes valuation model. Assumptions used are the same as those for acquired awards as disclosed in Note 11 of Notes to Consolidated Financial Statements. |